← FDA DRUG APPROVALS

FDA ANDA · ANDA085742

AMITRIPTYLINE HYDROCHLORIDE

Sponsor: MUTUAL PHARM

APPLICATION
ANDA085742
TYPE
ANDA
ORIGINAL APPROVAL
1977-07-13
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

AMITRIPTYLINE HYDROCHLORIDEDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 65AP
1995-10-16Labeling · Supplement 64AP
1994-12-23Manufacturing (CMC) · Supplement 63AP
1994-10-11Manufacturing (CMC) · Supplement 62AP
1993-09-03Labeling · Supplement 61AP
1992-04-03Manufacturing (CMC) · Supplement 58AP
1992-04-03Manufacturing (CMC) · Supplement 60AP
1992-01-31Labeling · Supplement 57AP
1991-12-30Labeling · Supplement 56AP
1990-02-28Manufacturing (CMC) · Supplement 54AP
1990-02-28Labeling · Supplement 55AP
1989-04-07Manufacturing (CMC) · Supplement 34AP
1987-09-29Manufacturing (CMC) · Supplement 51AP
1987-09-29Manufacturing (CMC) · Supplement 52AP
1987-09-29Manufacturing (CMC) · Supplement 50AP
1987-03-20Manufacturing (CMC) · Supplement 49AP
1986-02-03Manufacturing (CMC) · Supplement 47AP
1985-11-18Manufacturing (CMC) · Supplement 45AP
1985-11-18Manufacturing (CMC) · Supplement 46AP
1982-05-11Manufacturing (CMC) · Supplement 31AP
1982-05-11Manufacturing (CMC) · Supplement 30AP
1977-07-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →